Mobivity (MFON) 10-Q 14 Aug 23 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2023	Aug. 14, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-53851
Entity Registrant Name	Mobivity Holdings Corp.
Entity Central Index Key	0001447380
Entity Tax Identification Number	26-3439095
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3133 West Frye Road, # 215
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85226
City Area Code	(877)
Local Phone Number	282-7660
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		67,292,393

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 529,471	$ 426,740
Accounts receivable, net of allowance for doubtful accounts $9,423 and $34,446, respectively	542,711	1,081,183
Other current assets	423,371	195,017
Total current assets	1,495,553	1,702,940
Right to use lease assets	878,380	981,896
Intangible assets and software development costs, net	99,257	194,772
Other assets	127,417	137,917
TOTAL ASSETS	2,600,607	3,017,525
Current liabilities
Accounts payable	3,481,685	3,412,612
Accrued interest	442,269	443,448
Accrued and deferred personnel compensation	297,572	569,347
Deferred revenue and customer deposits	469,750	902,727
Operating lease liability, current	263,663	251,665
Other current liabilities	15,162	49,541
Total current liabilities	6,349,447	8,373,128
Non-current liabilities
Operating lease liability	801,492	936,924
Total non-current liabilities	4,726,060	3,449,306
Total liabilities	11,075,507	11,822,434
Stockholders’ deficit
Common stock, $0.001 par value; 100,000,000 shares authorized; 65,797,567 and 61,311,155, shares issued and outstanding	65,798	61,311
Equity payable	307,318	324,799
Additional paid-in capital	113,868,248	108,806,353
Accumulated other comprehensive loss	(69,598)	(100,963)
Accumulated deficit	(122,646,666)	(117,896,409)
Total stockholders’ deficit	(8,474,900)	(8,804,909)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	2,600,607	3,017,525
Related Party [Member]
Current liabilities
Notes payable, net - current maturities	1,361,250	2,711,171
Non-current liabilities
Notes payable, net - long term	3,894,345	2,481,290
Nonrelated Party [Member]
Current liabilities
Notes payable, net - current maturities	18,096	32,617
Non-current liabilities
Notes payable, net - long term	$ 30,223	$ 31,092

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 9,423	$ 34,446
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	65,797,567	61,311,155
Common stock, shares outstanding	65,797,567	61,311,155

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues
Revenues	$ 1,861,171	$ 1,867,162	$ 3,742,653	$ 3,896,731
Cost of revenues	1,371,206	1,202,749	2,437,781	2,377,697
Gross profit	489,965	664,413	1,304,872	1,519,034
Operating expenses
General and administrative	1,071,153	897,984	2,615,259	2,105,160
Sales and marketing	602,911	566,270	1,294,131	1,163,771
Engineering, research, and development	804,343	873,836	1,538,718	1,576,059
Depreciation and amortization	36,582	110,421	100,484	234,733
Total operating expenses	2,514,989	2,448,511	5,548,592	5,079,723
Loss from operations	(2,025,024)	(1,784,098)	(4,243,720)	(3,560,689)
Other income/(expense)
Loss of settlement of debt			(10,857)
Interest expense	(244,443)	(167,126)	(482,889)	(326,953)
Settlement Losses	(2,500)		(12,500)
Foreign currency gain	(115)	(510)	(291)	2,809
Total other income/(expense)	(247,058)	(167,636)	(506,537)	(324,144)
Loss before income taxes	(2,272,082)	(1,951,734)	(4,750,257)	(3,884,833)
Income tax expense
Net loss	(2,272,082)	(1,951,734)	(4,750,257)	(3,884,833)
Other comprehensive loss, net of income tax
Foreign currency translation adjustments	(137)	12,261	31,365	(634)
Comprehensive loss	$ (2,272,219)	$ (1,939,473)	$ (4,718,892)	$ (3,885,467)
Net loss per share:
Basic	$ (0.03)	$ (0.03)	$ (0.07)	$ (0.07)
Diluted	$ (0.03)	$ (0.03)	$ (0.07)	$ (0.07)
Weighted average number of shares:
Basic	65,670,815	58,602,319	63,884,441	57,921,596
Diluted	65,670,815	58,602,319	63,884,441	57,921,596

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Stockholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Equity Payable [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance at Dec. 31, 2021	$ 55,411	$ 100,862	$ 102,446,921	$ (52,088)	$ (107,835,287)	$ (5,284,181)
Beginning balance, shares at Dec. 31, 2021	55,410,695
Issuance of common stock for warrant exercise	$ 3,188		2,547,364			2,550,552
Issuance of common stock for warrant exercise, shares	3,188,190
Stock based compensation			589,650			589,650
Foreign currency translation adjustment				(12,895)		(12,895)
Net loss					(1,933,099)	(1,933,099)
Fair value of options issued with related party debt			6,201			6,201
Ending balance at Mar. 31, 2022	$ 58,599	100,862	105,590,136	(64,983)	(109,768,386)	(4,083,772)
Ending balance, shares at Mar. 31, 2022	58,598,885
Beginning balance at Dec. 31, 2021	$ 55,411	100,862	102,446,921	(52,088)	(107,835,287)	(5,284,181)
Beginning balance, shares at Dec. 31, 2021	55,410,695
Foreign currency translation adjustment						(634)
Net loss						(3,884,833)
Ending balance at Jun. 30, 2022	$ 59,661	100,862	106,699,502	(52,722)	(111,720,120)	(4,912,817)
Ending balance, shares at Jun. 30, 2022	59,661,385
Beginning balance at Mar. 31, 2022	$ 58,599	100,862	105,590,136	(64,983)	(109,768,386)	(4,083,772)
Beginning balance, shares at Mar. 31, 2022	58,598,885
Stock based compensation			211,775			211,775
Foreign currency translation adjustment				12,261		12,261
Net loss					(1,951,734)	(1,951,734)
Fair value of options issued with related party debt			48,654			48,654
Issuance of common stock for PIPE financing	$ 1,062		848,937			849,999
Issuance of common stock for PIPE financing, shares	1,062,500
Ending balance at Jun. 30, 2022	$ 59,661	100,862	106,699,502	(52,722)	(111,720,120)	(4,912,817)
Ending balance, shares at Jun. 30, 2022	59,661,385
Beginning balance at Dec. 31, 2022	$ 61,311	324,799	108,806,353	(100,963)	(117,896,409)	(8,804,909)
Beginning balance, shares at Dec. 31, 2022	61,311,155
Issuance of common stock for warrant exercise	$ 3,587		3,583,900			3,587,487
Issuance of common stock for warrant exercise, shares	3,587,487
Issuance of common stock for settlement of interest payable on related party debt	$ 164	(7,713)	223,773			216,224
Issuance of common stock for settlement of interest payable on related party debt, shares	163,757
RSU’s issued - termination of a director’s service	$ 545		(545)
RSU's issued - termination of a director's service, shares	545,012
Stock based compensation			810,157			810,157
Foreign currency translation adjustment				31,502		31,502
Net loss					(2,478,175)	(2,478,175)
Ending balance at Mar. 31, 2023	$ 65,607	317,086	113,423,638	(69,461)	(120,374,584)	(6,637,714)
Ending balance, shares at Mar. 31, 2023	65,607,411
Beginning balance at Dec. 31, 2022	$ 61,311	324,799	108,806,353	(100,963)	(117,896,409)	(8,804,909)
Beginning balance, shares at Dec. 31, 2022	61,311,155
Foreign currency translation adjustment						31,365
Net loss						(4,750,257)
Ending balance at Jun. 30, 2023	$ 65,798	307,318	113,868,248	(69,598)	(122,646,666)	(8,474,900)
Ending balance, shares at Jun. 30, 2023	65,797,567
Beginning balance at Mar. 31, 2023	$ 65,607	317,086	113,423,638	(69,461)	(120,374,584)	(6,637,714)
Beginning balance, shares at Mar. 31, 2023	65,607,411
Issuance of common stock for settlement of interest payable on related party debt	$ 191	(9,768)	216,033			206,456
Issuance of common stock for settlement of interest payable on related party debt, shares	190,156
Stock based compensation			228,577			228,577
Foreign currency translation adjustment				(137)		(137)
Net loss					(2,272,082)	(2,272,082)
Ending balance at Jun. 30, 2023	$ 65,798	$ 307,318	$ 113,868,248	$ (69,598)	$ (122,646,666)	$ (8,474,900)
Ending balance, shares at Jun. 30, 2023	65,797,567

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
OPERATING ACTIVITIES
Net loss	$ (4,750,257)	$ (3,884,833)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on Settlement of Debt - related party	10,857
Bad debt expense	(545)	18,631
Stock-based compensation	1,038,734	801,425
Depreciation and amortization expense	120,403	241,191
Amortization of Debt Discount	63,134	50,895
Increase (decrease) in cash resulting from changes in:
Accounts receivable	539,017	(268,498)
Other current assets	638	(123,940)
Operating lease assets/liabilities	(19,918)	(6,461)
Other assets	(276)
Accounts payable	69,073	(219,401)
Prepaid Expenses	(228,732)
Accrued interest	410,644	271,896
Accrued and deferred personnel compensation	(272,193)	(317,323)
Other liabilities - current	(34,379)	(9,071)
Deferred revenue and customer deposits	(432,977)	(74,191)
Net cash used in operating activities	(3,486,777)	(3,519,680)
INVESTING ACTIVITIES
Purchases of equipment	(14,111)	(6,993)
Net cash used in investing activities	(14,111)	(6,993)
FINANCING ACTIVITIES
Payments on notes payable	(16,684)	(15,947)
Proceeds from Related Party Debt		500,000
Proceeds from conversion of common stock warrants		849,999
Proceeds from conversion of common stock warrants	3,587,487	2,550,552
Net cash provided by financing activities	3,570,803	3,884,604
Effect of foreign currency translation on cash flow	32,816	(1,895)
Net Change in cash	102,731	356,036
Cash at beginning of period	426,740	735,424
Cash at end of period	529,471	1,091,460
Supplemental disclosures:
Interest		29,541
Non-cash investing and financing activities:
Fair Value of Options issued with related party debt		54,855
Shares issued for settlement of debt - related party	411,823
Shares issued for stock payable for settlement of debt - related party	223,937
Par Value pf RSU’s issued - termiation of director’s service	$ 545

Nature of Operations and Basis

Nature of Operations and Basis of Presentation	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Basis of Presentation	1. Nature of Operations and Basis of Presentation Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands, and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On November 14, 2018, we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable, and intellectual property. We generate revenue by charging the resellers, brands, and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC on April 3, 2023. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of June 30, 2023, and for the three and six months ended June 30, 2023 and 2022. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results may differ from these estimates. Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did not affect previously reported net losses. Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. Cash We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts. Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of June 30, 2023, and December 31, 2022, we recorded an allowance for doubtful accounts of $ 9,423 34,446 Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2022. As a result of these tests, we had a total impairment charge of $ 963,659 Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year twenty years The Company’s evaluation of its goodwill and intangible assets resulted in no impairment charges for the six months ended June 30, 2023 and 2022, respectively. Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the Financial Accounting Standards Board (“FASB”) guidance for the costs of computer software to be sold, leased, or otherwise marketed (Accounting Standards Codification subtopic 985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. The technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are canceled or abandoned are charged to product development expenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four-month The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development assets resulted in no Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate. Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of ASC subtopic 830-10, Foreign Currency Matters . Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps: ● identification of the contract, or contracts, with a customer; ● identification of the performance obligations in the contract; ● identification of the transaction price; ● allocation of the transaction price to the performance obligations in the contract; and ● recognition of revenue when, or as, we satisfy a performance obligation. During the six months ended June 30, 2023 and 2022, two 51 49 Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the three months ended June 30, 2023 and 2022 , the comprehensive loss was $ 2,272,219 1,939,473 4,718,892 3,885,467 Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period. Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials. Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $ 114,978 188,825 Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained. Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and six months ended June 30, 2023 and 2022, we had securities outstanding which could potentially dilute basic earnings per share in the future. Stock based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive. Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). ASU 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The Company adopted ASU 2020-06 on January 1, 2022.

Going Concern

Going Concern	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	3. Going Concern We had $ 529,471 4,750,257 3,486,777 3,884,833 3,519,680 3.6 1.1 As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $ 122.6

Goodwill and Purchased Intangib

Goodwill and Purchased Intangibles	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Purchased Intangibles	4. Goodwill and Purchased Intangibles Goodwill The carrying value of goodwill at each of June 30, 2023 and December 31, 2022 was $ 0 The following table presents details of our purchased intangible assets as of June 30, 2023 and December 31, 2022: Intangible assets Schedule of Goodwill and Intangible Assets Balance at December 31, 2022 Additions Impairments Amortization Fx and Other Balance at June 30, 2023 Patents and trademarks $ 52,698 $ — $ — $ (2,445 ) $ 1 $ 50,254 Customer and merchant relationships 30,690 — — $ (12,276 ) — 18,414 Trade names 8,050 — — $ (3,221 ) — 4,829 $ 91,438 $ — $ — $ (17,942 ) $ 1 $ 73,497 The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one year twenty years Amortization expense for intangible assets was $ 17,942 71,478 Amortization expense for intangible assets was $ 8,972 32,590 The estimated future amortization expense of our intangible assets as of June 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 17,942 2024 12,639 2025 4,891 2026 4,891 2027 4,891 Thereafter 28,243 Total $ 73,497

Software Development Costs

Software Development Costs	6 Months Ended
	Jun. 30, 2023
Research and Development [Abstract]
Software Development Costs	5. Software Development Costs The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities. The following table presents details of our software development costs as of June 30, 2023 and December 31, 2022: Schedule of Software Development Costs Balance at December 31, 2022 Additions Amortization Balance at June 30, 2023 Software Development Costs $ 103,334 $ — $ (77,574 ) $ 25,760 $ 103,334 $ — $ (77,574 ) $ 25,760 Software development costs are being amortized on a straight-line basis over their estimated useful life of two Amortization expense for software development costs was $ 35,629 71,974 Amortization expense for software development costs was $ 77,574 145,263 The estimated future amortization expense of software development costs as of June 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 21,254 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 25,760

Operating Lease Assets

Operating Lease Assets	6 Months Ended
	Jun. 30, 2023
Operating Lease Assets
Operating Lease Assets	6. Operating Lease Assets The Company entered into a lease agreement on February 1, 2021, for 8,898 25,953 28,733 50% 110,000 110,000 878,380 1,065,155 The following are additional details related to leases recorded on our balance sheet as of June 30, 2023: Schedule of Additional Details Related to Leases Leases Classification Balance at Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets $ 878,380 Total lease assets $ 878,380 Liabilities Current Operating lease liabilities Operating lease liabilities $ 263,663 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 801,492 Total lease liabilities $ 1,065,155 The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate: Schedule of Lessee, Operating Lease Liability Year ending December 31, 2023 $ 162,389 2024 330,894 2025 337,568 2026 344,241 2027 28,733 Thereafter — Total future lease payments 1,203,825 Less: imputed interest (138,670 ) Total $ 1,065,155 Schedule of Lease Cost Weighted Average Remaining Lease Term (years) Operating leases 3.58 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Expe

Notes Payable and Interest Expense	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Notes Payable and Interest Expense	7. Notes Payable and Interest Expense The following table presents details of our notes payable as of June 30, 2023 and December 31, 2022: Schedule of Debt Facility Maturity Interest Rate Balance at June 30, 2023 Balance at December 31, 2022 ACOA Note February 1, 2024 — 18,096 34,231 TD Bank December 31, 2023 — 30,223 29,478 Related Party Note various 15 % 4,983,720 5,192,461 Total Debt 5,032,039 5,256,170 Less current portion (1,379,346 ) (2,743,788 ) Long-term debt, net of current portion $ 3,652,693 $ 2,512,382 ACOA Note On November 6, 2017, Livelenz (a wholly-owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014, with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement, the note will mature, and the commitments will terminate on February 1, 2024. The monthly principal payment amount of $ 3,000 3,500 4,000 4,500 2,215 During the six months ended June 30, 2023 we repaid $ 16,684 TD Bank Loan On April 22, 2020, we entered into a commitment loan with TD Bank under the Canadian Emergency Business Account (“CEBA”), in the principal aggregate amount of $ 40,000 0 no 33 67 Related Party Notes Secured Promissory Notes On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Agreement was amended on November 11, 2022. The Company can borrow up to $ 6,000,000 The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen percent ( 15 1.67 36 the Company has agreed to issue to the Lender additional warrants entitling the Lender to purchase a number of shares of the Company’s common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the “VWAP”). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP. Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments 15 6,000,000 1.08 On January 31, 2023, the Company then entered into Amendment No. 1 (the “Amendment”), which amends our existing Credit Facility Agreement, dated as of November 11, 2022, between the Company and Thomas B. Akin, and any convertible notes issued thereunder. The Amendment amends the existing Credit Facility Agreement to extend the maturity of the agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the agreement is to be paid quarterly in shares of our common stock, at a price per share equal to the volume-weighted average price of our common stock quoted on the Over-The Counter Venture Market operated by OTC Markets Group Inc. (“OTCQB®”) over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible notes to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the existing Credit Facility Agreement. The Amendment was considered a debt modification as the cash flows under the amended terms do not differ by at least 10% from the cash flows under the original agreement. During the six months ended June 30, 2023, a total of $ 391,319 362,335 10,315 59,983 As of June 30, 2023, the Company had drawn a total of $ 5,173,125 439,968 179,948 Unsecured Promissory Note On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $ 271,875 15 2 no 33,017 On January 31, 2023, the Lender agreed to postpone the 24-month repayment period During the six months ended June 30, 2023, a total of $ 20,504 18,987 542 3152 As of June 30, 2023, the Company had an outstanding principal balance of $ 271,875 20,504 9,457 Interest Expense Interest expense was $ 244,443 167,126 Interest expense was $ 482,889 326,953

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Stockholders’ Equity	8. Stockholders’ Equity Common Stock and Equity Payable 2022 On February 9, 2022, 17 3,188,190 0.80 2,550,552 3,188,190 1.50 three 382,048 On June 29, 2022, the Company received private investment funds to purchase 1,062,500 0.80 850,000 1,062,500 1.50 On August 24, 2022, the Company received private investment funds to purchase 1,500,000 0.80 1,200,000 1,500,000 1.50 On November 13, 2022 a total of 140,185 151,398 2,259 On November 13, 2022 a total of 9,585 10,352 162 On December 31, 2022 a total of $ 166,432 154,106 44,325 On December 31, 2022 a total of $ 10,423 9,651 2,757 2023 On January 31, 2023 a total of 545,012 no On March 27, 2023 a total of 154,106 166,432 44,325 On March 27, 2023 a total of 9,651 10,423 2,757 On March 31, 2023 a total of $ 195,171 st quarter 180,715 10,315 On March 31, 2023 a total of $ 10,196 of interest for 1 st 9,441 shares of common stock that was issued on May 8, 2023. The company recorded a loss of settlement of interest payable of $ 542 . During March, 15 3,587,487 1.00 3,557,487 1,793,745 2.00 577,000 63 0.3216 On June 30, 2023 a total of $ 196,148 181,620 On June 30, 2023 a total of $ 10,309 9,546 During the six months ended June 30, 2023 a total of 163,757 As of June 30, 2023 we had an equity payable balance of $ 307,318 . Stock-based Plans Stock Option Activity The following table summarizes stock option activity for the six months ended June 30, 2023. Share Based Payment Arrangement Options Activity Options Outstanding at December 31, 2021 6,246,466 Granted 1,375,000 Exercised — Forfeited/canceled (330,623 ) Expired (599,627 ) Outstanding at December 31, 2022 6,691,216 Granted 295,000 Exercised — Forfeited/canceled (72,916 ) Expired (1,330,592 ) Outstanding at June 30, 2023 5,582,708 2022 On March 29, 2022, the Company granted one 150,000 0.8289 25 36 72.33 0.54 81,035 On May 16, 2022, the Company granted three 45,000 0.97 25 36 73.45 0.642608 28,917 On September 22, 2022, the Company granted one 1,000,000 0.98 25 36 76.15 0.697499 697,499 2023 During the six months ended June 30, 2023 the Company granted three 295,000 0.98 25 36 75.76 0.705183 208,029 Stock-Based Compensation Expense from Stock Options and Warrants The impact on our results of operations of recording stock-based compensation expense for the three and six months ended June 30, 2023 and 2022 were as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 General and administrative $ 53,750 $ 377,415 $ 118,783 $ 505,661 Sales and marketing 71,796 22,344 140,442 35,211 Engineering, research, and development 38,029 64,059 72,504 130,549 Total $ 163,575 $ 463,818 $ 331,729 $ 671,421 Valuation Assumptions The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the six months ended June 30, 2023 and 2022. Schedule of Stock Options Valuation Assumptions Six Months Ended June 30, 2023 2022 Risk-free interest rate 3.37 % 2.55 % Expected life (years) 7.00 6.00 Expected dividend yield — % — % Expected volatility 75.76 % 72.59 % The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options. The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on the historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of the Company’s stock-based awards. The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts. The expected volatility in 2023 and 2022 is based on the historical publicly traded price of our common stock. Restricted stock units The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2022 and for the six months ended June 30, 2023: Schedule of Restricted Stock Unit Activity Shares Outstanding at December 31, 2021 1,685,141 Awarded 244,792 Released — Canceled/forfeited/expired — Outstanding at December 31, 2022 1,929,933 Awarded 141,484 Released (545,012 ) Canceled/forfeited/expired — Outstanding at June 30, 2023 1,526,405 Expected to vest at June 30, 2023 1,526,405 Vested at June 30, 2023 1,526,405 Unvested at June 30, 2023 — Unrecognized expense at June 30, 2023 $ — 2022 On March 29, 2022, the company granted four 78,420 65,002 0.829 On May 16, 2022, the company granted four 54,168 65,002 1.20 On September 30, 2022, the company granted four 65,100 65,002 On December 31, 2022 the Company granted four 47,104 65,004 1.38 During the six months ended June 30, 2022, the Company recorded $ 65,002 2023 On March 31, 2023, the company grated granted four 61,342 65,002 1.05 On June 30, 2023, the company granted four 80,160 65,003 0.81 In the six months ended June 30, 2023, the Company recorded $ 130,005 Stock Based Compensation from Restricted Stock The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and six months ended June 30, 2023 and 2022 was as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 General and administrative $ 65,002 $ 65,002 $ 130,005 $ 130,004 Sales and marketing $ — $ — $ — $ — Total $ 65,002 $ 65,002 $ 130,005 $ 130,004 As of June 30, 2023, there was no Warrants The following table summarizes investor warrants as of June 30, 2023 and the years ended December 31, 2022 and 2021: Schedule of Investor Warrants Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised — $ — — Canceled/forfeited/expired (3,188,190 ) $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 Granted 1,793,745 $ — — Exercised ( 3,587,487 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at June 30, 2023 4,354,156 $ 1.69 2.14 2022 On February 9, 2022, 17 3,188,190 0.80 2,550,553 3,188,190 1.50 three 382,048 On June 29, 2022, six private investors purchased 1,062,500 1.50 1,062,500 0.80 850,000 On August 24, 2022, five private investors purchased 1,500,000 1.50 1,500,000 0.80 1,200,000 2023 During the six months ended June 30, 2023, 15 3,587,487 1.00 3,557,487 1,793,745 2.00 three-year 577,000 63 0.3216

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	9. Fair Value Measurements Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value. The following table presents assets that are measured and recognized at fair value as of June 30, 2023 on a recurring and non-recurring basis: Schedule of Fair Value Measurements Recurring and Nonrecurring Description Level 1 Level 2 Level 3 Gains Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 99,257 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2022 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ —

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies Litigation The company had a pending legal proceeding related to a Telephone Consumer Protection Act (“TCPA”) violation. This is a putative class action complaint alleging that the defendant initiated telephone solicitations through text messages in violation of the Florida Telephone Solicitation Act, Fla. Stat. § 501.059 four 12,500 Operating Lease As described in Note 6, the Company has a lease agreement for 8,898 25,953 28,733 50% 878,380 1,065,155

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	11. Related Party Transactions Secured Promissory Notes On June 30, 2021, we entered into a Credit Facility Agreement with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Facility Agreement was amended on November 11, 2022 to allow the Company to borrow up to $ 6,000,000 Unsecured Promissory Note On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $ 271,875 15 For more details regarding the two related party transactions, please refer to Note 7 - Notes Payable and Interest Expense. Related Party Warrant Exercise On March 2, 2023, Thomas Akin exercised his common stock purchase warrant for 749,987 1.00 749,987 374,994 2.00 three 120,598 63 0.3216 On February 7, 2022, Talkot Fund LP exercised their common stock purchase warrant for 750,000 1.00 750,000 375,000 2.00 three-year 120,600 63 0.3216

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	12. Subsequent Events On July 17, 2023, a total of 181,620 On July 17, 2023, a total of 9,546 2023 Warrants Exercise During the quarter ended August 07, 2023, 5 1,303,660 0.82 1,069,000.38. 2,607,318 0.82 three

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did not affect previously reported net losses.
Acquisitions	Acquisitions We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.
Cash	Cash We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.
Accounts Receivable, Allowance for Doubtful Accounts and Concentrations	Accounts Receivable, Allowance for Doubtful Accounts and Concentrations Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate. As of June 30, 2023, and December 31, 2022, we recorded an allowance for doubtful accounts of $ 9,423 34,446
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit. We conducted our annual impairment tests of goodwill as of December 31, 2022. As a result of these tests, we had a total impairment charge of $ 963,659 Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year twenty years The Company’s evaluation of its goodwill and intangible assets resulted in no impairment charges for the six months ended June 30, 2023 and 2022, respectively.
Software Development Costs	Software Development Costs Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the Financial Accounting Standards Board (“FASB”) guidance for the costs of computer software to be sold, leased, or otherwise marketed (Accounting Standards Codification subtopic 985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. The technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered ‘research and development’ that are not capitalized are immediately charged to engineering, research, and development expense. Capitalized costs for those products that are canceled or abandoned are charged to product development expenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four-month The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development assets resulted in no
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.
Foreign Currency Translation	Foreign Currency Translation The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of ASC subtopic 830-10, Foreign Currency Matters .
Revenue Recognition and Concentrations	Revenue Recognition and Concentrations Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue. Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues. We determine revenue recognition under ASC 606 through the following steps: ● identification of the contract, or contracts, with a customer; ● identification of the performance obligations in the contract; ● identification of the transaction price; ● allocation of the transaction price to the performance obligations in the contract; and ● recognition of revenue when, or as, we satisfy a performance obligation. During the six months ended June 30, 2023 and 2022, two 51 49
Comprehensive Income (Loss)	Comprehensive Income (Loss) Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the three months ended June 30, 2023 and 2022 , the comprehensive loss was $ 2,272,219 1,939,473 4,718,892 3,885,467
Stock-based Compensation	Stock-based Compensation We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.
Research and Development Expenditures	Research and Development Expenditures Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.
Advertising Expense	Advertising Expense Direct advertising costs are expensed as incurred and consist primarily of trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $ 114,978 188,825
Income Taxes	Income Taxes We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.
Net Loss Per Common Share	Net Loss Per Common Share Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and six months ended June 30, 2023 and 2022, we had securities outstanding which could potentially dilute basic earnings per share in the future. Stock based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments. In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). ASU 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The Company adopted ASU 2020-06 on January 1, 2022.

Goodwill and Purchased Intang_2

Goodwill and Purchased Intangibles (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill and Intangible Assets	The following table presents details of our purchased intangible assets as of June 30, 2023 and December 31, 2022: Intangible assets Schedule of Goodwill and Intangible Assets Balance at December 31, 2022 Additions Impairments Amortization Fx and Other Balance at June 30, 2023 Patents and trademarks $ 52,698 $ — $ — $ (2,445 ) $ 1 $ 50,254 Customer and merchant relationships 30,690 — — $ (12,276 ) — 18,414 Trade names 8,050 — — $ (3,221 ) — 4,829 $ 91,438 $ — $ — $ (17,942 ) $ 1 $ 73,497
Schedule of Finite Lived Intangible Assets Future Amortization Expense	The estimated future amortization expense of our intangible assets as of June 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 17,942 2024 12,639 2025 4,891 2026 4,891 2027 4,891 Thereafter 28,243 Total $ 73,497

Software Development Costs (Tab

Software Development Costs (Tables)	6 Months Ended
	Jun. 30, 2023
Finite-Lived Intangible Assets [Line Items]
Schedule of Software Development Costs	The following table presents details of our software development costs as of June 30, 2023 and December 31, 2022: Schedule of Software Development Costs Balance at December 31, 2022 Additions Amortization Balance at June 30, 2023 Software Development Costs $ 103,334 $ — $ (77,574 ) $ 25,760 $ 103,334 $ — $ (77,574 ) $ 25,760
Schedule of Finite Lived Intangible Assets Future Amortization Expense	The estimated future amortization expense of our intangible assets as of June 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 17,942 2024 12,639 2025 4,891 2026 4,891 2027 4,891 Thereafter 28,243 Total $ 73,497
Software and Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Schedule of Finite Lived Intangible Assets Future Amortization Expense	The estimated future amortization expense of software development costs as of June 30, 2023 is as follows: Schedule of Finite Lived Intangible Assets Future Amortization Expense Year ending December 31, Amount 2023 $ 21,254 2024 4,506 2025 — 2026 — 2027 — Thereafter — Total $ 25,760

Operating Lease Assets (Tables)

Operating Lease Assets (Tables)	6 Months Ended
	Jun. 30, 2023
Operating Lease Assets
Schedule of Additional Details Related to Leases	The following are additional details related to leases recorded on our balance sheet as of June 30, 2023: Schedule of Additional Details Related to Leases Leases Classification Balance at Assets Current Operating lease assets Operating lease assets $ — Noncurrent Operating lease assets Noncurrent operating lease assets $ 878,380 Total lease assets $ 878,380 Liabilities Current Operating lease liabilities Operating lease liabilities $ 263,663 Noncurrent Operating lease liabilities Noncurrent operating lease liabilities $ 801,492 Total lease liabilities $ 1,065,155
Schedule of Lessee, Operating Lease Liability	The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate: Schedule of Lessee, Operating Lease Liability Year ending December 31, 2023 $ 162,389 2024 330,894 2025 337,568 2026 344,241 2027 28,733 Thereafter — Total future lease payments 1,203,825 Less: imputed interest (138,670 ) Total $ 1,065,155
Schedule of Lease Cost	Schedule of Lease Cost Weighted Average Remaining Lease Term (years) Operating leases 3.58 Weighted Average Discount Rate Operating leases 6.75 %

Notes Payable and Interest Ex_2

Notes Payable and Interest Expense (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The following table presents details of our notes payable as of June 30, 2023 and December 31, 2022: Schedule of Debt Facility Maturity Interest Rate Balance at June 30, 2023 Balance at December 31, 2022 ACOA Note February 1, 2024 — 18,096 34,231 TD Bank December 31, 2023 — 30,223 29,478 Related Party Note various 15 % 4,983,720 5,192,461 Total Debt 5,032,039 5,256,170 Less current portion (1,379,346 ) (2,743,788 ) Long-term debt, net of current portion $ 3,652,693 $ 2,512,382

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Payment Arrangement Options Activity	The following table summarizes stock option activity for the six months ended June 30, 2023. Share Based Payment Arrangement Options Activity Options Outstanding at December 31, 2021 6,246,466 Granted 1,375,000 Exercised — Forfeited/canceled (330,623 ) Expired (599,627 ) Outstanding at December 31, 2022 6,691,216 Granted 295,000 Exercised — Forfeited/canceled (72,916 ) Expired (1,330,592 ) Outstanding at June 30, 2023 5,582,708
Schedule of Stock Options Valuation Assumptions	The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the six months ended June 30, 2023 and 2022. Schedule of Stock Options Valuation Assumptions Six Months Ended June 30, 2023 2022 Risk-free interest rate 3.37 % 2.55 % Expected life (years) 7.00 6.00 Expected dividend yield — % — % Expected volatility 75.76 % 72.59 %
Schedule of Restricted Stock Unit Activity	The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2022 and for the six months ended June 30, 2023: Schedule of Restricted Stock Unit Activity Shares Outstanding at December 31, 2021 1,685,141 Awarded 244,792 Released — Canceled/forfeited/expired — Outstanding at December 31, 2022 1,929,933 Awarded 141,484 Released (545,012 ) Canceled/forfeited/expired — Outstanding at June 30, 2023 1,526,405 Expected to vest at June 30, 2023 1,526,405 Vested at June 30, 2023 1,526,405 Unvested at June 30, 2023 — Unrecognized expense at June 30, 2023 $ —
Schedule of Investor Warrants	The following table summarizes investor warrants as of June 30, 2023 and the years ended December 31, 2022 and 2021: Schedule of Investor Warrants Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Outstanding at December 31, 2021 3,246,690 $ 2.26 3.59 Granted 6,089,398 $ — — Exercised — $ — — Canceled/forfeited/expired (3,188,190 ) $ — — Outstanding at December 31, 2022 6,147,898 $ 1.45 2.27 Granted 1,793,745 $ — — Exercised ( 3,587,487 ) $ — — Canceled/forfeited/expired — $ — — Outstanding at June 30, 2023 4,354,156 $ 1.69 2.14
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Stock-based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for the three and six months ended June 30, 2023 and 2022 were as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 General and administrative $ 53,750 $ 377,415 $ 118,783 $ 505,661 Sales and marketing 71,796 22,344 140,442 35,211 Engineering, research, and development 38,029 64,059 72,504 130,549 Total $ 163,575 $ 463,818 $ 331,729 $ 671,421
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Stock-based Compensation Expense	The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and six months ended June 30, 2023 and 2022 was as follows: Schedule of Stock-based Compensation Expense 2023 2022 2023 2022 Three Months Ended Six Months Ended June 30, June 30, 2023 2022 2023 2022 General and administrative $ 65,002 $ 65,002 $ 130,005 $ 130,004 Sales and marketing $ — $ — $ — $ — Total $ 65,002 $ 65,002 $ 130,005 $ 130,004

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements Recurring and Nonrecurring	Schedule of Fair Value Measurements Recurring and Nonrecurring Description Level 1 Level 2 Level 3 Gains Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 99,257 $ — The following table presents assets that are measured and recognized at fair value as of December 31, 2022 on a recurring and non-recurring basis: Description Level 1 Level 2 Level 3 Gains Goodwill (non-recurring) $ — $ — $ — $ — Intangibles, net (non-recurring) $ — $ — $ 194,772 $ —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Product Information [Line Items]
Accounts receivable, allowance for doubtful accounts	$ 9,423		$ 9,423		$ 34,446
Goodwill, Impairment loss					$ 963,659
Finite-lived intangible asset, useful life (year)	2 years		2 years
Comprehensive loss	$ 2,272,219	$ 1,939,473	$ 4,718,892	$ 3,885,467
Advertising expense			$ 114,978	$ 188,825
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member]
Product Information [Line Items]
Number of major customers			51%	49%
Computer Software, Intangible Asset [Member]
Product Information [Line Items]
Finite-lived intangible asset, useful life (year)	24 months		24 months
Finite-lived intangible asset, useful life (year)	$ 0	$ 0
Minimum [Member]
Product Information [Line Items]
Finite-lived intangible asset, useful life (year)	1 year		1 year
Maximum [Member]
Product Information [Line Items]
Finite-lived intangible asset, useful life (year)	20 years		20 years

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended				6 Months Ended
	Aug. 30, 2023	Feb. 28, 2023	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Subsequent Event [Line Items]
Cash, cash equivalents, and federal funds sold			$ 529,471				$ 529,471
Net loss			2,272,082	$ 2,478,175	$ 1,951,734	$ 1,933,099	4,750,257	$ 3,884,833
Net cash used in operating activities							3,486,777	$ 3,519,680
Proceeds from warrant exercises		$ 3,600,000
Accumulated deficit			$ 122,646,666				$ 122,646,666		$ 117,896,409
Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from warrant exercises	$ 1,100,000

Schedule of Goodwill and Intang

Schedule of Goodwill and Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Beginning balance			$ 91,438
Additions
Impairments
Amortization	$ (8,972)	$ (32,590)	(17,942)	$ (71,478)
Fx and Other			1
Ending balance	73,497		73,497
Patents and Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			52,698
Additions
Impairments
Amortization			(2,445)
Fx and Other			1
Ending balance	50,254		50,254
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			30,690
Additions
Impairments
Amortization			(12,276)
Fx and Other
Ending balance	18,414		18,414
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Beginning balance			8,050
Additions
Impairments
Amortization			(3,221)
Fx and Other
Ending balance	$ 4,829		$ 4,829

Schedule of Finite Lived Intang

Schedule of Finite Lived Intangible Assets Future Amortization Expense (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
2023	$ 17,942
2024	12,639
2025	4,891
2026	4,891
2027	4,891
Thereafter	28,243
Total	73,497	$ 91,438
Total	73,497	$ 91,438
Software and Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
2023	21,254
2024	4,506
2025
2026
2027
Thereafter
Total	25,760
Total	$ 25,760

Goodwill and Purchased Intang_3

Goodwill and Purchased Intangibles (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 0		$ 0		$ 0
Finite-lived intangible asset, useful life (year)	2 years		2 years
Amortization of intangible assets	$ 8,972	$ 32,590	$ 17,942	$ 71,478
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (year)	1 year		1 year
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (year)	20 years		20 years

Schedule of Software Developmen

Schedule of Software Development Costs (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Capitalized computer software net			$ 103,334
Additions
Amortization			(77,574)
Capitalized computer software net	$ 25,760		25,760
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Capitalized computer software net			103,334
Additions
Amortization	(35,629)	$ (71,974)	(77,574)	$ (145,263)
Capitalized computer software net	$ 25,760		$ 25,760

Software Development Costs (Det

Software Development Costs (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	2 years		2 years
Capitalized computer software, amortization			$ 77,574
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	24 months		24 months
Capitalized computer software, amortization	$ 35,629	$ 71,974	$ 77,574	$ 145,263

Schedule of Additional Details

Schedule of Additional Details Related to Leases (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Operating Lease Assets
Operating lease assets, Current
Operating lease assets, Non-current	878,380
Operating lease assets	878,380	$ 981,896
Operating lease liabilities, Current	263,663	251,665
Operating lease liabilities, Non-current	801,492	$ 936,924
Operating lease liabilities	$ 1,065,155

Schedule of Lessee, Operating L

Schedule of Lessee, Operating Lease Liability (Details)	Jun. 30, 2023 USD ($)
Operating Lease Assets
2023	$ 162,389
2024	330,894
2025	337,568
2026	344,241
2027	28,733
Thereafter
Total future lease payments	1,203,825
Less: imputed interest	(138,670)
Total	$ 1,065,155

Schedule of Lease Cost (Details

Schedule of Lease Cost (Details)	Jun. 30, 2023
Operating Lease Assets
Weighted average remaining lease term (years) operating leases (year)	3 years 6 months 29 days
Weighted average discount rate, operating leases	6.75%

Operating Lease Assets (Details

Operating Lease Assets (Details Narrative)	Feb. 01, 2021 USD ($) ft²	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Operating lease assets		$ 878,380	$ 981,896
Operating lease liability		1,065,155
Lease Ending January 2027 [Member]
Lessee, Lease, Description [Line Items]
Area of real estate property | ft²	8,898
Represents abatement percentage of operating lease for lessee	50%
Deposit assets	$ 110,000
Fixed assets contributed by lessor	110,000
Operating lease assets		878,380
Operating lease liability		$ 1,065,155
Lease Ending January 2027 [Member] | Minimum [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense	25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Lessee, Lease, Description [Line Items]
Monthly rental expense	$ 28,733

Schedule of Debt (Details)

Schedule of Debt (Details) - USD ($)	6 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Apr. 22, 2020
Short-Term Debt [Line Items]
Debt and lease obligation, total	$ 5,032,039	$ 5,256,170
Long term debt current	(1,379,346)	(2,743,788)
Long-term debt, net of current portion	$ 3,652,693	2,512,382
ACOA Note [Member]
Short-Term Debt [Line Items]
Maturity	Feb. 01, 2024
Debt and lease obligation, total	$ 18,096	34,231
TD Bank [Member]
Short-Term Debt [Line Items]
Maturity	Dec. 31, 2023
Debt and lease obligation, total	$ 30,223	29,478
Interest Rate			0%
Related Party Note [Member]
Short-Term Debt [Line Items]
Debt and lease obligation, total	$ 4,983,720	$ 5,192,461
Interest Rate	15%

Notes Payable and Interest Ex_3

Notes Payable and Interest Expense (Details Narrative)									3 Months Ended		6 Months Ended
	Jan. 31, 2023	Aug. 01, 2022 CAD ($)	Aug. 01, 2021 CAD ($)	Jul. 01, 2021 USD ($) shares	Jun. 30, 2021 USD ($) $ / shares	Apr. 22, 2020 USD ($)	Nov. 01, 2019 CAD ($)	Nov. 06, 2017 CAD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) shares	Jun. 30, 2023 CAD ($) shares	Jun. 30, 2022 USD ($)	Nov. 13, 2022 $ / shares	Nov. 11, 2022 USD ($)	Aug. 24, 2022 $ / shares shares	Jun. 29, 2022 $ / shares shares	Feb. 09, 2022 $ / shares
Short-Term Debt [Line Items]
Class of warrant or right, exercise price of warrants or Rrights | $ / shares																$ 0.80	$ 0.80	$ 0.80
Interest expense, debt									$ 244,443	$ 167,126	$ 482,889		$ 326,953
Discounts Debt											63,134		$ 50,895
Warrants to purchase shares | shares																1,500,000	1,062,500
ACOA Note [Member] | Livelenz [Member]
Short-Term Debt [Line Items]
Debt instrument periodic payment		$ 4,500	$ 4,000				$ 3,500	$ 3,000			16,684	$ 2,215
TD Bank [Member]
Short-Term Debt [Line Items]
Debt instrument periodic payment						$ 0
Debt instrument face amount						$ 40,000
Interest rate						0%
Percent of loan forgiven						33%
Percent of loan repaid requirement for forgiveness						67%
Credit Agreement [Member] | Director [Member]
Short-Term Debt [Line Items]
Interest rate					15%										15%
Line of credit facility maximum borrowing capacity					$ 6,000,000				6,000,000		6,000,000				$ 6,000,000
Class of warrant or right, exercise price of warrants or Rrights | $ / shares					$ 1.67
Warrant exercisable period afte issuance of financing					36 months
Warrant exercisable period afte issuance of financing					the Company has agreed to issue to the Lender additional warrants entitling the Lender to purchase a number of shares of the Company’s common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the “VWAP”). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.
Frequency of period payment					24 equal monthly installments
Debt instrument monthly conversion of interest rate per share | $ / shares														$ 1.08
Interest expense, debt											$ 391,319
Debt conversion converted instrument shares issued 1 | shares											362,335	362,335
Gain (loss) on settlement of debt											$ 10,315
Discounts Debt											59,983
Proceeds from long term lines of credit including interest											5,173,125
Interest payable current and non current									439,968		439,968
Debt instrument discount									179,948		179,948
Unsecured Promissory Notes [Member]
Short-Term Debt [Line Items]
Debt instrument face amount				$ 271,875
Interest rate				15%
Frequency of period payment	24-month repayment period
Interest expense, debt											$ 20,504
Debt conversion converted instrument shares issued 1 | shares											18,987	18,987
Gain (loss) on settlement of debt											$ 542
Discounts Debt											3,152
Proceeds from long term lines of credit including interest											271,875
Interest payable current and non current									20,504		20,504
Debt instrument discount									$ 9,457		$ 9,457
Pre-payment penalty rate				2%
Payments for Commissions				$ 0
Warrants to purchase shares | shares				33,017

Share Based Payment Arrangement

Share Based Payment Arrangement Options Activity (Details) - shares				6 Months Ended	12 Months Ended
	Sep. 22, 2022	May 16, 2022	Mar. 29, 2022	Jun. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options, Granted	1,000,000	45,000	150,000	295,000
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options outstanding, Beginning balance				6,691,216	6,246,466
Options, Granted				295,000	1,375,000
Options, Exercised
Options, Forfeited/canceled				(72,916)	(330,623)
Options, Expired				(1,330,592)	(599,627)
Options outstanding, Ending balance				5,582,708	6,691,216

Schedule of Stock-based Compens

Schedule of Stock-based Compensation Expense (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total	$ 163,575	$ 463,818	$ 331,729	$ 671,421
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total	53,750	377,415	118,783	505,661
Share-Based Payment Arrangement, Option [Member] | Selling and Marketing Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total	71,796	22,344	140,442	35,211
Share-Based Payment Arrangement, Option [Member] | Engineering and Research and Development Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total	38,029	64,059	72,504	130,549
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total	65,002	65,002	130,005	130,004
Restricted Stock Units (RSUs) [Member] | General and Administrative Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total	65,002	65,002	130,005	130,004
Restricted Stock Units (RSUs) [Member] | Selling and Marketing Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Total

Schedule of Stock Options Valua

Schedule of Stock Options Valuation Assumptions (Details)						6 Months Ended
	Feb. 14, 2023	Sep. 22, 2022	May 16, 2022	Mar. 29, 2022	Feb. 07, 2022	Jun. 30, 2023	Jun. 30, 2022
Equity [Abstract]
Risk-free interest rate						3.37%	2.55%
Expected life (years) (Year)						7 years	6 years
Expected dividend yield
Expected volatility	63%	76.15%	73.45%	72.33%	63%	75.76%	72.59%

Schedule of Restricted Stock Un

Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member] - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding, Beginning balance	1,929,933	1,685,141
Shares, Awarded	141,484	244,792
Shares, Released	(545,012)
Shares, Canceled/forfeited/expired
Shares outstanding, Ending balance	1,526,405	1,929,933
Shares, Expected to vest at June 30, 2023	1,526,405
Shares, Vested at June 30, 2023	1,526,405
Shares, Unvested at June 30, 2023
Unrecognized expense at June 30, 2023

Schedule of Investor Warrants (

Schedule of Investor Warrants (Details) - Investor Warrant [Member] - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Shares outstanding, Beginning balance	6,147,898	3,246,690
Weighted Average Exercise Price, Outstanding, Beginning balance	1.45	2.26
Outstanding (in shares)	2 years 1 month 20 days	2 years 3 months 7 days	3 years 7 months 2 days
Warrants, Granted	1,793,745	6,089,398
Warrants, Exercised	3,587,487
Warrants, Canceled/forfeited/expired		(3,188,190)
Shares outstanding, Ending balance	4,354,156	6,147,898	3,246,690
Weighted Average Exercise Price, Outstanding, Ending balance	1.69	1.45	2.26

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative)											1 Months Ended			3 Months Ended				6 Months Ended		12 Months Ended
	Mar. 27, 2023 USD ($) shares	Feb. 14, 2023 $ / shares	Nov. 13, 2022 USD ($) shares	Sep. 22, 2022 USD ($) Integer $ / shares shares	Aug. 24, 2022 USD ($) $ / shares shares	Jun. 29, 2022 USD ($) $ / shares shares	May 16, 2022 USD ($) Integer $ / shares shares	Mar. 29, 2022 USD ($) Integer $ / shares shares	Feb. 09, 2022 USD ($) Integer $ / shares shares	Feb. 07, 2022 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) Integer $ / shares shares	Jan. 31, 2023 shares	Sep. 30, 2022 USD ($) Integer shares	Jun. 30, 2023 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) Integer $ / shares shares	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($) shares	Jun. 30, 2023 USD ($) Integer $ / shares shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) Integer $ / shares shares	Mar. 02, 2023 $ / shares shares
Class of Warrant or Right [Line Items]
Number of warrant holding | Integer									17
Issuance of common stock for warrant exercise (in shares) | shares					1,500,000	1,062,500			3,188,190
Exercise price | $ / shares					$ 0.80	$ 0.80			$ 0.80
Number of warrants to purchase common stock | shares					1,500,000	1,062,500
Issuance of common stock for warrant exercise (in shares)															$ 3,587,487		$ 2,550,552
Equity amount payable														$ 307,318				$ 307,318		$ 324,799
Number of employees, awards granted | Integer				1			3	1										3
Granted, shares | shares				1,000,000			45,000	150,000										295,000
Share-based compensation option grant per share | $ / shares				$ 0.98			$ 0.97	$ 0.8289										$ 0.98
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period				36 months			36 months	36 months										36 months
Expected volatility		63%		76.15%			73.45%	72.33%		63%								75.76%	72.59%
Option fair value | $ / shares		$ 0.3216		$ 0.697499			$ 0.642608	$ 0.54		$ 0.3216								$ 0.705183
Share-based compensation arrangement by share-based payment award, call option value				$ 697,499			$ 28,917	$ 81,035										$ 208,029
Additional capital					$ 1,200,000													$ 3,557,487
Vesting on the First Anniversary [Member]
Class of Warrant or Right [Line Items]
Share-based compensation arrangement by share-based payment award, award vesting rights, percentage				25%			25%	25%										25%
Former Director [Member]
Class of Warrant or Right [Line Items]
Stock issued during period, Shares, issued for services | shares												545,012
Board of Directors [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense																		$ 130,005	$ 65,002
Related Party [Member]
Class of Warrant or Right [Line Items]
Debt instrument, shares issued | shares																		163,757
Conversion of Interest Payable on Related Party Debt into Common Stock [Member]
Class of Warrant or Right [Line Items]
Gain (loss) on Settlement of Interest Payable																				44,325
Debt instrument, shares issued | shares																		10,309
Number of shares equity payable for the issuance of common stock | shares																		9,546
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Former Director [Member]
Class of Warrant or Right [Line Items]
Debt instrument, shares issued | shares																		196,148
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Director [Member]
Class of Warrant or Right [Line Items]
Issuance of common stock for debt settlement (in shares) | shares	154,106		140,185
Interest Payable	$ 166,432		$ 151,398
Gain (loss) on Settlement of Interest Payable	$ 44,325		$ 2,259
Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Talkot Fund LP [Member]
Class of Warrant or Right [Line Items]
Issuance of common stock for debt settlement (in shares) | shares	9,651		9,585
Interest Payable	$ 10,423		$ 10,352
Gain (loss) on Settlement of Interest Payable	$ 2,757		$ 162
Conversion of Interest Payable to Common Stock [Member]
Class of Warrant or Right [Line Items]
Gain (loss) on Settlement of Interest Payable											$ 10,315
Debt Conversion, Original Debt, Amount											$ 195,171									$ 166,432
Debt instrument, shares issued | shares											180,715									154,106
Conversion of Interest Payable to Common Stock2 [Member]
Class of Warrant or Right [Line Items]
Gain (loss) on Settlement of Interest Payable											$ 542									$ 2,757
Debt Conversion, Original Debt, Amount											$ 10,196									$ 10,423
Debt instrument, shares issued | shares											9,441									9,651
Common Stock [Member]
Class of Warrant or Right [Line Items]
Number of warrant holding | Integer																		15
Issuance of common stock for warrant exercise (in shares) | shares															3,587,487		3,188,190
Exercise price | $ / shares					$ 0.80	$ 0.80								$ 1				$ 1
Number of warrants to purchase common stock | shares					1,500,000	1,062,500								3,587,487				3,587,487
Issuance of common stock for debt settlement (in shares) | shares														190,156	163,757
Issuance of common stock for warrant exercise (in shares)															$ 3,587		$ 3,188
Common Stock [Member] | Conversion of Interest Payable on Related Party Debt into Common Stock [Member] | Former Director [Member]
Class of Warrant or Right [Line Items]
Number of shares equity payable for the issuance of common stock | shares																		181,620
Warrant [Member]
Class of Warrant or Right [Line Items]
Expected volatility																		63%
Option fair value | $ / shares																		$ 0.3216
Warrants [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense									$ 382,048								$ 382,048	$ 577,000
Restricted Stock [Member] | Former Director [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense																		0
Restricted Stock Units (RSUs) [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense														$ 65,002		$ 65,002		130,005	$ 130,004
Share-based payment arrangement, nonvested award
Restricted Stock Units (RSUs) [Member] | Board of Directors [Member]
Class of Warrant or Right [Line Items]
Number of employees, awards granted | Integer							4	4					4		4			4		4
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period | shares							54,168	78,420					65,100		61,342			80,160		47,104
Share-based compensation arrangement by share based payment award, equity instruments other than options, grants in period, value							$ 65,002	$ 65,002					$ 65,002		$ 65,002			$ 65,003		$ 65,004
Closing stock price on date of the grant per share | $ / shares							$ 1.20	$ 0.829							$ 1.05			$ 0.81		$ 1.38
Inducement Warrant [Member]
Class of Warrant or Right [Line Items]
Issuance of common stock for warrant exercise (in shares) | shares					1,200,000	850,000			2,550,552
Exercise price | $ / shares					$ 1.50	$ 1.50			$ 1.50		$ 2			$ 2	$ 2			$ 2
Warrants and rights outstanding, term									3 years					3 years				3 years
Number of warrants to purchase common stock | shares											1,793,745			1,793,745	1,793,745			1,793,745
Additional capital						$ 850,000			$ 2,550,553
Inducement Warrant [Member] | Measurement Input, Price Volatility [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input											0.63				0.63
Inducement Warrant [Member] | Option Fair Value [Member]
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, measurement input											0.3216				0.3216
Inducement Warrant [Member] | Director [Member]
Class of Warrant or Right [Line Items]
Exercise price | $ / shares										$ 2											$ 2
Warrants and rights outstanding, term										3 years											3 years
Inducement Warrant [Member] | Warrant [Member]
Class of Warrant or Right [Line Items]
Stock-based compensation expense											$ 577,000
Common Stock Purchase Warrants [Member]
Class of Warrant or Right [Line Items]
Number of warrant holding | Integer											15
Issuance of common stock for warrant exercise (in shares) | shares											3,587,487
Exercise price | $ / shares											$ 1				$ 1
Issuance of common stock for warrant exercise (in shares)											$ 3,557,487
Common Stock Purchase Warrants [Member] | Director [Member]
Class of Warrant or Right [Line Items]
Exercise price | $ / shares										$ 1											$ 1
Number of warrants to purchase common stock | shares										375,000											374,994
Additional capital										$ 750,000

Schedule of Fair Value Measurem

Schedule of Fair Value Measurements Recurring and Nonrecurring (Details) - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)
Fair Value, Inputs, Level 1 [Member] | Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)
Fair Value, Inputs, Level 2 [Member] | Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)
Fair Value, Inputs, Level 3 [Member] | Fair Value, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Goodwill (non-recurring)
Intangibles, net (non-recurring)	$ 99,257	$ 194,772

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)		3 Months Ended		6 Months Ended
	Feb. 01, 2021 USD ($) ft²	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) Integer	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Loss Contingencies [Line Items]
Loss contingency claims settled number | Integer				4
Settlement losses		$ 2,500		$ 12,500
Operating lease asset		878,380		878,380		$ 981,896
Operating lease liability		1,065,155		1,065,155
Lease Ending January 2027 [Member]
Loss Contingencies [Line Items]
Area of a real estate property | ft²	8,898
Represents abatement percentage of operating lease for lessee	50%
Operating lease asset		878,380		878,380
Operating lease liability		$ 1,065,155		$ 1,065,155
Lease Ending January 2027 [Member] | Minimum [Member]
Loss Contingencies [Line Items]
Represents monthly rental expense	$ 25,953
Lease Ending January 2027 [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Represents monthly rental expense	$ 28,733

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)										1 Months Ended	6 Months Ended
	Mar. 02, 2023	Feb. 14, 2023	Sep. 22, 2022	Aug. 24, 2022	Jun. 29, 2022	May 16, 2022	Mar. 29, 2022	Feb. 09, 2022	Feb. 07, 2022	Feb. 28, 2023	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Nov. 11, 2022	Jul. 01, 2021	Jun. 30, 2021
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1				$ 0.80	$ 0.80			$ 0.80
Proceeds from warrant exercises										$ 3,600,000
Class of warrant or right, number of securities called by warrants or rights				1,500,000	1,062,500
Expected volatility		63%	76.15%			73.45%	72.33%		63%		75.76%	72.59%
Option fair value		$ 0.3216	$ 0.697499			$ 0.642608	$ 0.54		$ 0.3216		$ 0.705183
Additional capital				$ 1,200,000							$ 3,557,487
Common Stock Purchase Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1													$ 1
Inducement Warrant [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1				$ 1.50	$ 1.50			$ 1.50			$ 2		$ 2
Class of warrant or right, number of securities called by warrants or rights											1,793,745		1,793,745
Warrants and rights outstanding, term								3 years			3 years
Additional capital					$ 850,000			$ 2,550,553
Warrant Issuance [Member]
Related Party Transaction [Line Items]
Stock-based compensation expense	$ 120,598								$ 120,600
Director [Member] | Common Stock Purchase Warrants [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercised during period	749,987								750,000
Class of warrant or right exercise price of warrants or rights1	$ 1								$ 1
Proceeds from warrant exercises	$ 749,987
Class of warrant or right, number of securities called by warrants or rights	374,994								375,000
Additional capital									$ 750,000
Director [Member] | Inducement Warrant [Member]
Related Party Transaction [Line Items]
Class of warrant or right exercise price of warrants or rights1	$ 2								$ 2
Warrants and rights outstanding, term	3 years								3 years
Credit Agreement [Member] | Director [Member]
Related Party Transaction [Line Items]
Line of credit facility maximum borrowing capacity											$ 6,000,000			$ 6,000,000		$ 6,000,000
Debt instrument interest rate stated percentage														15%		15%
Class of warrant or right exercise price of warrants or rights1																$ 1.67
Warrants and rights outstanding, term																36 months
Unsecured Promissory Notes [Member]
Related Party Transaction [Line Items]
Debt iinstrument face amount															$ 271,875
Debt instrument interest rate stated percentage															15%
Class of warrant or right, number of securities called by warrants or rights															33,017

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)						1 Months Ended
	Aug. 07, 2023 USD ($) Integer $ / shares shares	Jul. 17, 2023 shares	Aug. 24, 2022 shares	Jun. 29, 2022 shares	Feb. 09, 2022 Integer shares	Mar. 31, 2023 Integer shares	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Subsequent Event [Line Items]
Number of warrant holding | Integer					17
Issuance of common stock for warrant exercise			1,500,000	1,062,500	3,188,190
Additional capital | $							$ 113,868,248	$ 108,806,353
Common Stock Purchase Warrants [Member]
Subsequent Event [Line Items]
Number of warrant holding | Integer						15
Issuance of common stock for warrant exercise						3,587,487
Subsequent Event [Member] | Common Stock Purchase Warrants [Member]
Subsequent Event [Line Items]
Number of warrant holding | Integer	5
Issuance of common stock for warrant exercise	1,303,660
Exercise price | $ / shares	$ 0.82
Additional capital | $	$ 1,069,000.38
Number of warrants to purchase, shares	2,607,318
Number of warrants exercise price | $ / shares	$ 0.82
Number of warrants exercise price term	3 years
Subsequent Event [Member] | Talkot Fund LP [Member]
Subsequent Event [Line Items]
Issuance of common stock for debt settlement		9,546
Thomas Akin [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Issuance of common stock for debt settlement		181,620